Home > Event > On-Demand Webinars > Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models

Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models

Current and Novel
Since the first immune checkpoint blocker ipilimumab was approved by the US FDA in 2011, more drug companies have sought to develop their own immune therapy drugs. 
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

New drugs for the old enemy

Despite the efforts towards malaria eradication, the latest estimates show that the number of cases is rising and malaria continues to have a devastating impact on the most vulnerable populations.
Watch Now

Intelligent Infrastructure is Key to Unleashing Pharmacy Transformation

The management of the United States’ massive prescription drug spend is plagued by inefficient, manual processes and errors which exact enormous human and financial tolls on society.
Watch Now

Pharma Product Aggregation: Delivering Business Benefits Beyond Serialization

Systechone

The cost of returned medicines is estimated to be between $5-10 billion per year in the US alone. However, pharmaceutical companies are struggling to streamline the data flow and verification of returned saleable goods.
Watch Now

Creating a Circular Economy for the Pharmaceutical Packaging Industry

The pharma packaging sector is one of the most environmentally conscious segments of the overall pharma industry, driven in part by healthcare professionals and patients demonstrating.
Watch Now

New drugs for the old enemy

Despite the efforts towards malaria eradication, the latest estimates show that the number of cases is rising and malaria continues to have a devastating impact on the most vulnerable populations.
Watch Now

Intelligent Infrastructure is Key to Unleashing Pharmacy Transformation

The management of the United States’ massive prescription drug spend is plagued by inefficient, manual processes and errors which exact enormous human and financial tolls on society.
Watch Now

Pharma Product Aggregation: Delivering Business Benefits Beyond Serialization

Systechone

The cost of returned medicines is estimated to be between $5-10 billion per year in the US alone. However, pharmaceutical companies are struggling to streamline the data flow and verification of returned saleable goods.
Watch Now

Creating a Circular Economy for the Pharmaceutical Packaging Industry

The pharma packaging sector is one of the most environmentally conscious segments of the overall pharma industry, driven in part by healthcare professionals and patients demonstrating.
Watch Now
More On-Demand Webinars

Spotlight

resources

resource image

resource image

resource image